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Modification of B. subtilir EF-Tu by N-tosyl-L-phenylalanyl chloromethane destroyed its ability to promote protein syn- 
thesis and resulted in selective dissociation of the two binding activities of the protein for aminoacyl-tRNA. The modified 
EF-Tu was completely ineffective in the protection of the 3’-terminal CCA structure of tRNA against pancreatic ribo- 
nuclease, while remaining almost fully active in the protection of the ester bond between the 3’-terminal adenosine and 
the amino acid residue in aminoacyl-tRNA. 
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1. INTRODUCTION 
The formation of a ternary complex between a 
nonribosomal protein designated elongation factor 
Tu, aminoacyl-tRNA, and GTP is an obligatory 
step in the elongation cycle of protein synthesis. To 
date, about five different approaches have been 
used to estimate the affinity of EF-Tu - GTP for 
aminoacyl-tRNA: protection of the ester bond be- 
tween amino acid and tRNA by EF-Tu - GTP from 
nonenzymatic deacylation [I] - the hydrolysis pro- 
tection assay [2]; EF-Tu. GTP protection of the 
aminoacyl end of aminoacyl-tRNA from ribonu- 
clease digestion - the RNase-resistance assay 
[3-51; protection of EF-Tu by aminoacyl-tRNA 
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from labelling by N-tosyl-L-phenylalanyl chloro- 
methane - the TPCK assay [6-81; monitoring the 
fluorescence change that accompanies the associa- 
tion of EF-Tu - GTP and fluorescent aminoacyl- 
tRNA [9]; reduction by aminoacyl-tRNA of the 
amount of EF-Tu bound to nitrocellulose filters 
[lO,ll]. 
The first four assays are based on the binding 
properties of the acceptor stem of aminoacyl- 
tRNA. The mechanism of the filter assay is less ob- 
vious. Whereas the hydrolysis protection assay as 
well as the RNase-resistance assay approach the 
formation of the complex via the integrity of the 
aminoacyl-tRNA molecule, the specificity of the 
TPCK assay rests on the monitoring protein EF-Tu 
integrity. The rate of modification of an essential 
cysteine residue of prokaryotic EF-Tus in the 
Aspso-Cys-Pro-Glyss (,?Z CO/J) consensus equence 
is a measure of the affinity of individual ligands 
for the aminoacyl-tRNA-binding site of EF-Tu 
[6,7,121. 
In our previous experiments we found that 
modification of EF-Tu from E. coli or B. 
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stearothermophilus by TPCK resulted in a loss of 
its ability to catalyse protein synthesis because the 
aptitude to interact with aminoacyl-tRNA was 
abolished [13,14]. In the present study, we analys- 
ed the behaviour of TPCK-modified EF-Tu from 
another bacterium, 8. subtilis. To our surprise, we 
found that although the factor was completely 
unable to promote protein synthesis, the results of 
the hydrolysis protection assay did not indicate 
that it had lost its capacity to interact with 
aminoacyl-tRNA. 
2. MATERIALS AND METHODS 
The preparation of EF-Tu.GDP, EF-G, and 1.5 M NHdCI- 
washed ribosomes from B. subtilis by modified classical pro- 
cedures will be described elsewhere. EF-Tu, at least 95% pure, 
was 64% active in GTP-binding based on a standard 
nitrocellulose binding assay [lo]. The procedure for the 
preparation of E. coli [‘?]Phe-tRNA (713 cpm/pmol) has 
been described [15]. Pancreatic ribonuclease (EC 3.1.27.5) was 
purchased from Boehringer, nitrocellulose filters (HA type) 
from Millipore Corporation. All other chemicals were as 
reported in [16]. 
2.1. Assay of EF-Tu activities 
The ability of control or TPCK-treated EF-Tu from B. sub- 
tilis to interact with aminoacyl-tRNA was measured either by 
the hydrolysis protection assay [2] as described in [16] or by the 
ribonuclease-resistance assay [3] as described below. 10 pM EF- 
Tu was first preincubated with 0.8 mM GTP, 6 mM 
phosphoenolpyruvate, and 87 pg/ml pyruvate kinase in a buf- 
fer containing 20 mM Tris-HCl (pH 8.1), 12 mM magnesium 
acetate, 100 mM NHdCl, and 10 mM 2-mercaptoethanol for 
10 min at 35°C to form EF-Tu.GTP from EF-Tu.GDP. Then 
500 pmol EF-Tu.GTP was incubated with 90 pmol [‘4C]Phe- 
tRNA in 413 ~1 of reaction buffer containing 10 mM Tris-HCl 
(pH 7.6), 12 mM magnesium acetate, 40 mM NH&l, 10 mM 
2-mercaptoethanol, 3 mM phosphoenolpyruvate, 17.4 pg 
pyruvate kinase, and 0.05 mM GTP at 35°C for 3 min to form 
a ternary complex. The mixture was chilled to 4°C and a 100 pl 
aliquot was withdrawn and precipitated by 3 ml of cold 10% 
trichloroacetic acid to measure the initial radioactivity. To the 
rest of the reaction mixture 10~1 of pancreatic ribonuclease 
(0.1 mg/ml) was added and 100 ~1 aliquots were withdrawn at 
15, 40 and 90 s and precipitated by 3 ml of cold 10% 
trichloroacetic acid to stop the digestion. The precipitates were 
collected on Millipore filters, rinsed thrice with trichloroacetic 
acid, dried, and counted. Blank samples, containing the same 
components but without EF-Tu, were treated in the same way 
as the complete assay system and run simultaneously. The 
values obtained were subtracted from the values obtained with 
EF-Tu. The phenylalanine polymerization activity of EF-Tu 
was assayed in a buffer containing 10 mM Tris-HCl (pH 7.6), 
12 mM magnesium acetate, 40 mM NHdCl, and 10 mM 
2-mercaptoethanol, essentially as described in [15] except that 
EF-G and ribosomes from B. subtilis were used. 
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2.2. Inhibition of EF-Tu from B. subtilis by N-tosyl-L- 
phenylalanyl chloromethane 
A preparation of 7.9 FM EF-Tu.GDP in buffer containing 
20 mM Tris-HCl (pH 8.1), 10 mM magnesium acetate, 100 mM 
NH&l, 0.5% (v/v) glycerol, 0.5rM GDP, and 5% (v/v) 
methanol was incubated with 0.5 mM N-tosyl-L-phenylalanyl 
chloromethane at 4°C for 4-5 h. Control EF-Tu was incubated 
under the same conditions but without the reagent. Then ali- 
quots of control and TPCK-treated EF-Tu were tested in all 
three assays described above. 
3. RESULTS 
Treatment of EF-Tu from B. subtilis with N- 
tosyl-L-phenylalanyl chloromethane destroyed the 
ability of the factor to promote protein synthesis 
(fig.1). For E. coli and B. stearothermophilus 
elongation factors studied before, it had been 
established that TPCK-modified EF-Tus failed to 
catalyse polymerization because their interaction 
with aminoacyl-tRNA had been abolished [ 13,141. 
Therefore, B. subtilis EF-Tu modified by TPCK 
was also tested for this partial activity in one of the 
widely used assay systems - the hydrolysis protec- 
tion assay [2]. To our surprise, however, the fac- 
tor, fully inactive in polymerization, was only very 
slightly affected in its ability to protect from 
nonenzymatic deacylation (fig.2). The results of 
this assay thus indicated that, in contrast to E. coli 
or B. stearothermophilus EF-Tus, the ability of 
TPCK-modified EF-Tu from B. subtilis to interact 
with aminoacyl-tRNA was not affected. The 
modified protein was then screened for other func- 
tions to explain the inhibitory effect of TPCK. It 
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Fig.1. Effect of TPCK on EF-Tu activity. Control (0) and 
TPCK-treated (0) EF-Tu were assayed for activity promoting 
the poly(U)-directed phenylalanine polymerization as described 
in section 2. 
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Fig.2. Lack of inhibition of protection by TPCK-treated EF-Tu 
of the acyl linkage in phenylalanyl-tRNA against nonenzymatic 
hydrolysis. (0) Control EF-Tu; (0) TPCK-treated EF-Tu. 
was found that only the activity promoting the 
transfer of aminoacyl-tRNA onto the ribosome 
and the GTPase activity of the modified elonga- 
tion factor were partly inhibited, though not to the 
same extent as its polymerization activity (data not 
shown). This strongly suggested that despite the 
negative results of the hydrolysis protection assay 
the inactivation of EF-Tu must occur at the level of 
the formation of the EF-Tu-tRNA complex. 
Therefore, this ability of the TPCK-modified EF- 
Tu was tested again using a different assay, the 
RNase-resistance assay [3,5]. This time, as can be 
seen in fig.3, the protecting activity of the elonga- 
tion factor against ribonuclease was found almost 
completely abolished by the TPCK treatment. The 
rate of digestion of phenylalanyl-tRNA by 
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Fig.3. Effect of TPCK on protection by EF-Tu of aminoacyl- 
tRNA against digestion by pancreatic ribonuclease. (0) 
Control EF-Tu; (0) TPCK-treated EF-Tu. 
ribonuclease was almost the same irrespective of 
the presence or absence of the modified EF-Tu. 
4. DISCUSSION 
The treatment with TPCK made it possible for 
the first time to dissociate two activities of EF-Tu 
involved in binding with aminoacyl-tRNA: interac- 
tion with the acyl linkage between the 3 ‘-terminal 
adenosine and the phenylalanine residue of 
phenylalanyl-tRNA from the interaction with the 
3 ‘-terminal CC polynucleotide structure of the 
aminoacyl-tRNA. This implies that in B. subtilis 
EF-Tu, the binding site for the 3’-terminus of 
aminoacyl-tRNA involves at least two rather in- 
dependent regions: one for the polynucleotide 
structure (the target site for the ribonuclease) and 
the other for the ester bond of the 3 ‘-terminal 
aminoacyl-adenosine (susceptible to nonenzymatic 
deacylation). The former region can be selectively 
disabled by modification with TPCK, either direct- 
ly or through a conformational change(s), while 
the latter region is only slightly affected. This sug- 
gests that the 3’-end polynucleotide structure of 
aminoacyl-tRNA represents an essential region for 
EF-Tu binding, because lack of interaction at this 
region completely abolished the proteosynthetic 
activity of EF-Tu even though the interaction at 
the ester bond region was retained. 
The unexpected finding of discrepancy between 
the results obtained by the hydrolysis protection 
assay and by the RNase-resistance assay has also 
some methodological significance for determina- 
tion of equilibrium dissociation constants between 
EF-Tu and aminoacyl-tRNAs. Any assay based on 
a partial function of a protein only, need not 
necessarily detect all irregularities that can occur 
even within the same binding site of the protein. 
This may be still more relevant to heterologous 
systems consisting of components isolated from 
different species (e.g. as above: EF-Tu from B. 
subtilis, Phe-tRNA from E. cob]. 
We observed no such dissociation of partial 
functions in TPCK-labelled EF-Tu from E. co/i 
(unpublished results). This is interesting, because 
the target structure for TPCK, a tryptic peptide 15 
amino acid residues long, has the same sequence 
both in E. coli [12] and B. subtilis EF-Tus (un- 
published results). To understand these variations, 
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more detailed structural work on the elongation 
factors will be required. 
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